HARMONY offers a unique opportunity for researchers, clinicians and bioinformaticians to be a part of cutting-edge research that contributes to improving the lives of patients with blood cancer. Read about what can be gained from joining HARMONY as an Associated Member and the steps involved by viewing our fact sheet.
/Become%20member.png)
Become involved with HARMONY today! Contact us to find out how you can participate in ongoing and future research initiatives.
Stay up to date with our activities by visiting our news page.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
